Company intelligence / Profile preview

Atkinson Toxicology Consulting

Ownership: Private
Development stage: Other

Overview

Atkinson Toxicology Consulting, founded by Dr. John Atkinson, offers expert toxicological consulting services to support preclinical and clinical drug development. The company assists clients with regulatory strategy, study design, data interpretation, and risk assessment for pharmaceuticals and related products. No clinical results or pipeline as it does not develop its own therapeutics.

Industry: Drug Discovery Services

Partnerships

Not specified in available sources

Beyond the preview

Go deeper on Atkinson Toxicology Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atkinson Toxicology Consulting.

Explore the full profile